Alveolar macrophages and the innate sentinel response to Mycobacterium tuberculosis
Alissa Rothchild (University of Massachusetts Amherst) presents as part of the Department of Immunology’s Easton Seminar Series,
World TB Day: How EPIC researchers are creating better vaccines for tuberculosis and uncovering its financial burden for patients and families
Tuberculosis (TB) remains one of the world’s most deadly infectious threats and a significant global health challenge. The World Health Organization estimates that in 2021, 10.6 million people became sick with the disease and 1.6 million people died of TB, which is both preventable and curable. Learn more about how members of the University of Toronto’s Emerging and Pandemic Infections Consortium are working to tackle TB from multiple angles, from creating better vaccines to gaining a deeper understanding of TB’s financial toll on patients and families.